Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;39(11):e70015.
doi: 10.1002/gps.70015.

Plasminogen Activator Inhibitor-1 in the Pathophysiology of Late Life Depression

Affiliations
Review

Plasminogen Activator Inhibitor-1 in the Pathophysiology of Late Life Depression

L Métivier et al. Int J Geriatr Psychiatry. 2024 Nov.

Abstract

Introduction: Late life depression (LLD) is characterized by specific clinical features including a high frequency of vascular form and frequent antidepressant treatment resistance. The expression and functions of the serine protease inhibitor, Plasminogen Activator Inhibitor-1 (PAI-1) is known to be altered by aging, vascular damage, insulin levels associated with a sedentary lifestyle, chronic stress leading to hypercortisolemia, and inflammatory changes linked to stress responses. These phenomena would be implicated in LLD like vascular depression. This article thus aims to review the existing literature regarding the association between LLD and plasmatic levels of PAI-1, a marker of hypofibrinolysis. We hypothesize that increased age would be associated with changes in PAI-1 plasma level and function which influence LLD pathogenesis and its treatment.

Results: Although a large number of studies on PAI-1 changes in the elderly exist, studies about its implications in LLD are sparse. Despite heterogeneous findings regarding the direction of variation in plasmatic PAI-1 levels among elderly participants with LLD, all studies demonstrated an association between PAI-1 levels and current or remitted depressive symptoms. Moreover, disruptions in the concentrations of other biological markers influencing PAI-1 expression, such as cytokines or adipokines, were also observed, notably an increase in the levels of interleukins 6 and 8.

Discussion: LLD genesis appears to be influenced by PAI-1 regulatory loops which are implicated in senescence or cell death. The resistance to antidepressant treatment appears to be linked to distinct biological profiles involving inflammatory and fibrinolytic factors. Taken together these data suggest that PAI-1 pathway may be a promising target of treatment development efforts for LLD, and depression in general.

Keywords: antidepressant resistance; late‐life depression; plasminogen activator inhibitor 1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. United Nations Department for Economic and Social Affairs, World Population Prospects 2022: Summary of Results (New York, NY, USA: Office of the Director, Population Division, United Nations, 2023).
    1. I. Sninate and A. Bennana, “Impact of Population Ageing on Medical Consumption: Compulsory Health Insurance in Morocco,” Pan African Medical Journal 35 (2020): 93, https://doi.org/10.11604/pamj.2020.35.93.20716.
    1. N. Abdoli, N. Salari, N. Darvishi, et al., “The Global Prevalence of Major Depressive Disorder (MDD) Among the Elderly: A Systematic Review and Meta‐Analysis,” Neuroscience and Biobehavioral Reviews 132 (2022): 1067–1073, https://doi.org/10.1016/j.neubiorev.2021.10.041.
    1. F. Chuquilín‐Arista, T. Álvarez‐Avellón, and M. Menéndez‐González, “Prevalence of Depression and Anxiety in Parkinson Disease and Impact on Quality of Life : A Community‐Based Study in Spain,” Journal of Geriatric Psychiatry and Neurology 33, no. 4 (2020): 207–213, https://doi.org/10.1177/0891988719874130.
    1. F. Leles da Costa Dias, A. L. Teixeira, H. Cerqueira Guimarães, et al., “Prevalence of Late‐Life Depression and its Correlates in a Community‐Dwelling Low‐Educated Population Aged 75+ Years: The Pietà Study,” Journal of Affective Disorders 242 (2019): 173–179, https://doi.org/10.1016/j.jad.2018.08.012.

Publication types

MeSH terms

Grants and funding

LinkOut - more resources